BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21367970)

  • 1. Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomes.
    Edelstein K; Spiegler BJ; Fung S; Panzarella T; Mabbott DJ; Jewitt N; D'Agostino NM; Mason WP; Bouffet E; Tabori U; Laperriere N; Hodgson DC
    Neuro Oncol; 2011 May; 13(5):536-45. PubMed ID: 21367970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anesthesia Exposure during Therapy Predicts Neurocognitive Outcomes in Survivors of Childhood Medulloblastoma.
    Jacola LM; Anghelescu DL; Hall L; Russell K; Zhang H; Wang F; Peters JB; Rossi M; Schreiber JE; Gajjar A
    J Pediatr; 2020 Aug; 223():141-147.e4. PubMed ID: 32532646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study.
    Schreiber JE; Palmer SL; Conklin HM; Mabbott DJ; Swain MA; Bonner MJ; Chapieski ML; Huang L; Zhang H; Gajjar A
    Neuro Oncol; 2017 Nov; 19(12):1673-1682. PubMed ID: 29016818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive Function and Health-Related Quality of Life in Pediatric Korean Survivors of Medulloblastoma.
    Yoo HJ; Kim H; Park HJ; Kim DS; Ra YS; Shin HY
    J Korean Med Sci; 2016 Nov; 31(11):1726-1734. PubMed ID: 27709849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral white matter integrity and executive function in adult survivors of childhood medulloblastoma.
    Brinkman TM; Reddick WE; Luxton J; Glass JO; Sabin ND; Srivastava DK; Robison LL; Hudson MM; Krull KR
    Neuro Oncol; 2012 Sep; 14 Suppl 4(Suppl 4):iv25-36. PubMed ID: 23095827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing speed, attention, and working memory after treatment for medulloblastoma: an international, prospective, and longitudinal study.
    Palmer SL; Armstrong C; Onar-Thomas A; Wu S; Wallace D; Bonner MJ; Schreiber J; Swain M; Chapieski L; Mabbott D; Knight S; Boyle R; Gajjar A
    J Clin Oncol; 2013 Oct; 31(28):3494-500. PubMed ID: 23980078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late Morbidity and Mortality Among Medulloblastoma Survivors Diagnosed Across Three Decades: A Report From the Childhood Cancer Survivor Study.
    Salloum R; Chen Y; Yasui Y; Packer R; Leisenring W; Wells E; King A; Howell R; Gibson TM; Krull KR; Robison LL; Oeffinger KC; Fouladi M; Armstrong GT
    J Clin Oncol; 2019 Mar; 37(9):731-740. PubMed ID: 30730781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.
    Mulhern RK; Palmer SL; Merchant TE; Wallace D; Kocak M; Brouwers P; Krull K; Chintagumpala M; Stargatt R; Ashley DM; Tyc VL; Kun L; Boyett J; Gajjar A
    J Clin Oncol; 2005 Aug; 23(24):5511-9. PubMed ID: 16110011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors.
    Kao GD; Goldwein JW; Schultz DJ; Radcliffe J; Sutton L; Lange B
    Cancer; 1994 Aug; 74(3):965-71. PubMed ID: 8039126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrocephalus as a possible additional contributor to cognitive outcome in survivors of pediatric medulloblastoma.
    Hardy KK; Bonner MJ; Willard VW; Watral MA; Gururangan S
    Psychooncology; 2008 Nov; 17(11):1157-61. PubMed ID: 18636431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal associations between exposure to anesthesia and neurocognitive functioning in pediatric medulloblastoma.
    Partanen M; Anghelescu DL; Hall L; Schreiber JE; Rossi M; Gajjar A; Jacola LM
    Eur J Cancer; 2021 May; 148():103-111. PubMed ID: 33743477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma.
    Palmer SL; Hassall T; Evankovich K; Mabbott DJ; Bonner M; Deluca C; Cohn R; Fisher MJ; Morris EB; Broniscer A; Gajjar A
    Neuro Oncol; 2010 Dec; 12(12):1311-7. PubMed ID: 20713408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study.
    King AA; Seidel K; Di C; Leisenring WM; Perkins SM; Krull KR; Sklar CA; Green DM; Armstrong GT; Zeltzer LK; Wells E; Stovall M; Ullrich NJ; Oeffinger KC; Robison LL; Packer RJ
    Neuro Oncol; 2017 May; 19(5):689-698. PubMed ID: 28039368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss.
    Mulhern RK; Palmer SL; Reddick WE; Glass JO; Kun LE; Taylor J; Langston J; Gajjar A
    J Clin Oncol; 2001 Jan; 19(2):472-9. PubMed ID: 11208841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of long-term survival in young children with medulloblastoma.
    Johnson DL; McCabe MA; Nicholson HS; Joseph AL; Getson PR; Byrne J; Brasseux C; Packer RJ; Reaman G
    J Neurosurg; 1994 Jun; 80(6):1004-10. PubMed ID: 8189255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term neurocognitive outcomes in young adult survivors of childhood acute lymphoblastic leukemia.
    Edelstein K; D'agostino N; Bernstein LJ; Nathan PC; Greenberg ML; Hodgson DC; Millar BA; Laperriere N; Spiegler BJ
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):450-8. PubMed ID: 21646917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma.
    Schreiber JE; Gurney JG; Palmer SL; Bass JK; Wang M; Chen S; Zhang H; Swain M; Chapieski ML; Bonner MJ; Mabbott DJ; Knight SJ; Armstrong CL; Boyle R; Gajjar A
    Neuro Oncol; 2014 Aug; 16(8):1129-36. PubMed ID: 24497405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive deficits in medulloblastoma survivors and white matter loss.
    Mulhern RK; Reddick WE; Palmer SL; Glass JO; Elkin TD; Kun LE; Taylor J; Langston J; Gajjar A
    Ann Neurol; 1999 Dec; 46(6):834-41. PubMed ID: 10589535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and secondary malignancies in childhood medulloblastoma.
    Stavrou T; Bromley CM; Nicholson HS; Byrne J; Packer RJ; Goldstein AM; Reaman GH
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):431-6. PubMed ID: 11878577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse medical events associated with childhood cerebellar astrocytomas and medulloblastomas: natural history and relation to very long-term neurobehavioral outcome.
    Roncadin C; Dennis M; Greenberg ML; Spiegler BJ
    Childs Nerv Syst; 2008 Sep; 24(9):995-1002; discussion 1003. PubMed ID: 18581121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.